1. Home
  2. SLN vs PDS Comparison

SLN vs PDS Comparison

Compare SLN & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

N/A

Current Price

$19.76

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

N/A

Current Price

$92.54

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SLN
PDS
Founded
1994
1951
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2010
1998

Fundamental Metrics

Financial Performance
Metric
SLN
PDS
Price
$19.76
$92.54
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$19.75
★ $106.15
AVG Volume (30 Days)
★ 4.4M
108.4K
Earning Date
11-20-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $559,000.00
N/A
Revenue This Year
N/A
$11.64
Revenue Next Year
$131.31
$5.93
P/E Ratio
★ N/A
$884.15
Revenue Growth
N/A
★ N/A
52 Week Low
$4.19
$56.10
52 Week High
$19.87
$112.03

Technical Indicators

Market Signals
Indicator
SLN
PDS
Relative Strength Index (RSI) 78.21 49.71
Support Level $13.01 $85.14
Resistance Level $19.87 $102.00
Average True Range (ATR) 0.07 5.09
MACD -0.04 -0.96
Stochastic Oscillator 58.49 22.94

Price Performance

Historical Comparison
SLN
PDS

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

Share on Social Networks: